TP53 and melanoma: Lu and co-workers, for example, demonstrated that in melanoma a cyclin B1/cdk1 protein complex phosphorylates iASPP leading to the inhibition of iASPP dimerization, increased nuclear entry of iASPP monomers, as well as binding and inhibition of p53 [8].